About Us

Management

Sanovas is led by an experienced team of medical device executives. This team has launched hundreds of medical devices and has deep roots in visualization and interventional technologies.

larry-img
Jerry Katzman, MD - Chairman, President & CEO

Dr. Jerry Katzman is the Company’s Chief Executive Officer, President, and Chairman of the Board of Directors. Dr. Katzman has always been an entrepreneur, scientist, and pioneer in medical science. His focus has targeted various biotechnology companies, biopharma, and Wall Street. Upon completion of his medical training, Dr. Katzman joined a multi-specialty group practice in Brandon, FL where he founded and established the group’s department of ophthalmology. 

He then entered into a private practice where he designed and built one of the first state-licensed in office freestanding ambulatory surgical centers. The center also provided a multitude of services, including pharmacy, audiology, retinal dx, and treatment, as well as, general eye care, eye surgery and optical. In 1993, Dr. Katzman founded EyeCare International, the nation’s first and largest non-insurance based discount vision network consisting of over 13,000 provider locations.

After 17 years with Amacore Group, Inc. (successor to EyeCare International) retired as its Chief Medical Officer and continued his work on healthcare initiatives to promote affordable healthcare and an emergency electronic medical records program. 

Thereafter, in 2008, co-founded Core Corporate Consulting Group, Inc. a private company designed to purchase and rejuvenate ailing public companies which were headed into bankruptcy. 

In 2013, founded Disruptor Technologies Inc., a marketing and consulting company, and served as the CEO. Disruptor was developed to research, identify, evaluate, obtain, develop, promote, manufacture, and/or market groundbreaking technologies in health and science. 

Dr. Katzman is also the host of the podcast Healthy, Strong, and Active: Your Strategy for Life.

Dr. Katzman graduated from Boston University with a B.S. in Biomedical Engineering in 1974 and thereafter earned his M.D. from the Universidad de Guadalajara in Jalisco, Mexico.

Fred Chasalow, Ph.D. - Member, Board of Directors

Dr. Fred Chasalow studied at leading institutions and was mentored in his research career with leading scientists. Dr. Kaplan literally wrote and edited Methods in Enzymology. Dr. Pharriss was one of the leading scientists at Upjohn for the discovery of prostaglandins. Dr. Lieberman was a leading steroid investigator including the first use of a steroid as a hapten to generate specific antibodies. Dr. Wall discovered taxol and vincristine.

Academic Career: From 1981 to 1995, Dr. Chasalow had a successful academic career and published regularly. His laboratory research activities were funded by his clinical laboratory service. Dr. Chasalow was the first Ph.D. member of the Lawson Wilkins Pediatric Endocrine Society. He had external grants from the NIH, March of Dimes, and State of New York. In 1991, Dr. Chasalow was promoted to Professor of Pediatrics, Director of Pediatric Research and Chief of the Pediatric Endocrine Laboratory, at the Maimonides Medical Center of SUNY Brooklyn. At SUNY Brooklyn, house officers from his classes won the award from the Kings County Medical association for the best presentation in two of the three years. Over this period, he made important contributions to clinical endocrinology in growth, sexual development, and diabetes. While Dr. Chasalow had an academic appointment, he served as an editor of Steroids and reviewed papers for many of the endocrine and pediatric journals.

Biotech Research Ventures: In 1991, Dr. Chasalow co-founded AMUR Research. In the course of investigating infants with inherited steroid biosynthetic defects, they identified a syndrome with an unknown defect. AMUR was founded to identify the missing hormone with the premise that it might be a useful drug. Between 1992 and 1998, AMUR raised ~$3M in Series A funding. Wilson Sonsini was the venture advisor to AMUR. At AMUR, Dr. Chasalow served as CEO and Chief Scientific Officer (CSO) and directed all laboratory activities, including six other doctoral scientists and 17 associates. He showed that the unknown hormone was a steroid phosphocholine ester. This was the first endogenous steroid phosphocholine ester discovered. he established a chemical synthesis group that synthesized the first synthetic steroid phosphocholine ester. As CSO, Dr. Chasalow was personally responsible for 6 patents. In 1998, the availability of venture capital ended. AMUR closed and its technology was purchased by SuperGen.

Financial Advisor: In 1998, Dr. Chasalow joined Morgan Stanley as a financial advisor and passed the FINRA Series 7 exam. Within 2 years, he was promoted to Associate Vice President. However, the events of 9-11 changed the market situation and he became an independent financial advisor. After 17 years of service, he retired on Dec. 31, 2015.

In July 2015, Dr. Chasalow was able to determine the chemical formula for the unknown hormone. He formed IOMA LLC and bought the IP from SuperGen. At IOMA, his functions as the Managing Partner and CSO and, at present, he is its sole (unpaid) employee. IOMA has received small grants from the SLO Foundation and a private obstetric practice. It has started laboratory activities with a CRADA at the Veterans Administration Medical Center (VAMC) in San Francisco. Last year, Dr. Chasalow published 3 papers and was appointed as a Visiting Professor at the VAMC.

From 1994-6, he served as a member of the Scientific Advisory Board for SuperGen.


Herbert L Gould, MD - Member, Board of Directors

Dr. Gould graduated from Bowdoin College and received an MD from Columbia’s College of Physicians and Surgeons.  He served his internship at the 1stMedical Division, Bellevue Hospital and was a resident at the Manhattan Eye, Ear & Throat Hospital, where, as senior resident, he initiated the Contact Lens Clinic. He continued his medical studies at the Institute of Ophthalmology (London), Harvard Medical School, and the Downstate Medical Center, NY, where he received a corneal fellowship which included Moorfields Eye Hospital, London. 

He was a co-founder of the Contact Lens Society of Ophthalmologists and the New York Intraocular Lens Implant Society. He was a founding member of the American Intraocular Lens Implant Society, now ASCRS, was elected to the International Intraocular Lens Implant Club (IIIC), and later was a founding member of the International Society of Refractive Surgery. Dr. 

Gould was the founder and first president of the New York Keratorefractive Society. He has been a Teaching Fellow at State University of New York, was Assistant Clinical Professor in Ophthalmology at State University of New York (Downstate), Associate Clinical Professor at New York Medical College, and served as an Instructor at the American Academy of Ophthalmology.   

Numerous presentations were made to professional associations in the US and throughout the world, including ophthalmological meetings in Athens, Prague, Stockholm, London, Vienna, Milan, Alexandria (Egypt), Shanghai, Korea, Algarve (Portugal) and Cannes, where he was also awarded a Bronze Medal from the Cannes Film Festival (Best Surgical Film: Corneal Transplant & Intra-Ocular Lens Implantation). He has published over 80 articles and chapters in professional books and journals. 

He has numerous professional memberships. 

He implanted the first intraocular lens in China with the IIIC. He trained in Russia and introduced radial keratotomy to the US and later helped develop the lasik technique.  He had one of the first lasers in NYC after FDA approval, and later helped set up the laser center at the New York Eye and Ear Infirmary.   He served as a Major in the U.S. Air Force, where he served as a Flight Surgeon, for five years.

mike-img
Pat Sheehan - Member, Board of Directors

After receiving a BA in Zoology from U.C.L.A. Ms. Sheehan became a research assistant in the Pharmacology Department, Stanford University School of Medicine. Research involved proving the presence of endorphins associated with narcotic addiction. 
In 1987-1989 Ms. Sheehan was employed as the Hardware Production Planner for 3Com (formerly Bridge Communications) planning the weekly assembly build schedules working closely with Purchasing and Production Control. On her own initiative, she compiled statistics that precipitated an immediate change in the assembly build process.

As a Marketing Manager for startups, NetBuy.com and FastParts.com, at times working with a Consultant, she managed all marketing communications and marketing programs, developed customer focused print and web advertising. Direct marketing campaigns included: direct mail, email, fax blasts e-newsletters. In a period of time “between PR agencies” she authored two articles published on behalf of NetBuy. In the early days of the Internet Ms. Sheehan worked closely with the development group to establish a web presence for NetBuy via submittals of meta tags, landing pages and placements of links to other websites, reviewing web metrics to determine marketing effectiveness. With a limited budget at FastParts she developed creative design for collateral and advertising images.

At Madge Networks Ms. Sheehan managed Madge Americas Executive Briefing Center and the CO-OP funds program for the Channel that grew from 36 to over 125 resellers. She established a new Company store for promotional gifts and coordinated logistics and budget for a 22 city executive seminar series. For Networld+Interop Trade Shows she coordinated all suite meetings for executives. Additional responsibilities included reporting Marcom budget tracking to the Finance Department.

Bookkeeping and Accounting for a private Architectural and construction company and for a Construction Subcontracting company. For both firms she used The American Contractor for all A/R, A/P, payroll, job estimating, job tracking, cash flow analysis, G/L entries and closing books at fiscal year end. For several years after her father’s death and prior to the sale of his company, she met monthly with his Controller and General Manager and CPA to review financials.

Ms. Sheehan holds both A1 and A2 shares of Sanovas preferred stock as well as common shares of Sanovas stock having exercised her Sanovas warrants.

Community volunteer work has included: PTA Vice-President, Junior League of San Jose, USTA Junior Tournament Director, and other volunteer work associated with her children’s activities.

Richard D. Wyatt - Member, Board of Directors

Richard D. Wyatt lives in Greenville, SC with his wife Pam (Fenning) Wyatt and trusty Irish Terrier, Chloe. He is ten years retired from the DC Federal Government and enjoys golfing, fishing, reading, and gardening. Since leaving the big city, he has found joy in tilting at homeowner association (HOA) windmills and writing about himself in the third person. He served on the Board of Directors of Swift Island (Mount Gilead, NC) HOA and Carshalton By The Bay (Lyman, SC) HOA in capacities as member-at-large and President. Both HOA positions required significant levels of effort, including questioning long term contracts/relationships and saving significant homeowner funds as a result. During his time as HOA Board member(s) he also competed multiple contracts, wrote HOA bylaws, rewrote homeowner covenants, initiated two reserve fund studies, and developed two HOA websites. Mr. Wyatt has also volunteered his time as a tax return preparer for lowincome seniors thru AARP/United Way and mentored middle school students thru Communities in Schools.

Mr. Wyatt studied at Florida State University and graduated magna cum laude majoring in Math/Computer Science and minoring in business management. Mr. Wyatt worked thirty three years for the Federal Government while living in northern Virginia. During seven years with the Defense Intelligence Agency (DIA) he held positions as computer programmer and branch manager. During 26 years with the Central Intelligence Agency he programmed computers, engineered computer networks, managed projects, managed contracts and completed his career as the Division Manager for Telephone engineering. He attained Level 3 (of 4) certification for contract management, Level 3 (of 4) for project management and certified as a Cisco Network Professional (CCNP). As a CIA manager of people, contracts, and budget, his main responsibility was to be a good steward of the taxpayer's money as well as do his part to produce finished intelligence for executive decision makers. Performing these duties honed Mr. Wyatt's skills in tactical planning, strategic planning, budget management, work content management, interpersonal skills, and open communication. As a contract manager, Mr. Wyatt followed fair competition processes and open communications as defined in Federal Acquisition Regulations (FAR).

FDA REGULATORY DISCLOSURE:
Sanovas Inc. is an emerging technology company. These products are investigational medical devices that have not been approved or cleared for use in the United States.